A single oral dose of fluconazole or a short course of an over-the-counter vaginal antifungal can clear most uncomplicated yeast infections within a few days, with many people feeling noticeably better within 24 to 48 hours of starting treatment. The catch is that “fast” depends on choosing the right treatment for the right problem, and roughly half of people who self-diagnose a yeast infection turn out to have something else entirely. Getting it right the first time is the real shortcut.
The Fastest Proven Treatments
For an uncomplicated vaginal yeast infection, two main options have strong evidence behind them: a single 150 mg oral dose of fluconazole (sold under the brand name Diflucan and generics, available by prescription in many countries and over the counter in some) and topical vaginal antifungals like clotrimazole or miconazole, which you can buy without a prescription in most pharmacies. Head-to-head trials show comparable clinical cure rates for both routes. In one trial comparing the two, about 85% of fluconazole-treated patients and 83% of clotrimazole-treated patients were clinically cured at the first follow-up, but fluconazole pulled ahead at longer follow-up, with far fewer patients still showing signs of infection weeks later.1PubMed. Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis
If speed is your priority and you have access to a prescription, the single-dose oral pill is hard to beat for convenience. You swallow one capsule and you’re done. Over-the-counter creams and suppositories typically come in 1-day, 3-day, or 7-day courses. The 1-day formulations use a higher concentration of drug, so they are not necessarily faster-acting; they just require fewer applications. Most people see symptom improvement within a day or two regardless of which format they choose, though complete resolution can take up to a week.
Getting Quick Relief From Itching and Burning
The antifungal itself is what cures the infection, but it does not instantly switch off the itching, redness, and swelling that make you miserable. Your body’s inflammatory response to the yeast is what causes most of the discomfort, and that inflammation takes a little time to calm down even after the yeast starts dying off.
Some antifungal products sold over the counter include a low-dose hydrocortisone cream for external use alongside the vaginal antifungal. This is not just marketing. Research on superficial fungal infections shows that adding a topical corticosteroid to an antifungal speeds up relief of itching and other inflammatory symptoms compared to antifungal treatment alone.2PubMed. The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses An expert panel reviewing the evidence concluded that the combination can improve patient compliance, reduce the risk of secondary bacterial infection from scratching, and may even enhance how well the antifungal works.3PubMed. Topical antifungal-corticosteroid combination therapy for the treatment of superficial mycoses: conclusions of an expert panel meeting If your OTC kit does not include one, a small amount of over-the-counter hydrocortisone applied externally to vulvar skin can help bridge the gap while the antifungal does its work. Do not put hydrocortisone inside the vagina.
Cool compresses and avoiding tight, non-breathable clothing also help. None of these comfort measures replace antifungal treatment, but they make the wait more bearable.
Are You Sure It Is a Yeast Infection?
This is the single most important question to answer before treating anything. Vaginal yeast infections are the second most common cause of vaginitis in women of childbearing age, but the symptoms overlap heavily with bacterial vaginosis, trichomoniasis, cytolytic vaginosis, and even contact dermatitis from soaps or laundry detergent.4Sexually Transmitted Infections. Evaluation of the diagnostic performance of four self-tests for vulvovaginal candidiasis Self-diagnosis has been shown repeatedly to have poor accuracy: studies find that only about half of women who believe they have a yeast infection actually do.
If you treat yourself with an antifungal and the real problem is bacterial vaginosis, you will not improve, the BV will continue, and you will have lost days wondering why the medication is not working. If you have never had a confirmed yeast infection before, or if your symptoms do not match the classic pattern of thick white discharge with intense itching, see a clinician. A simple swab and pH check can distinguish yeast from other causes quickly, and the right treatment started on day one is always faster than the wrong treatment started and abandoned.
When the Standard Approach Does Not Work
Most yeast infections are caused by Candida albicans, which responds well to the common azole antifungals. But a meaningful minority are caused by other species. Non-albicans species like C. glabrata, C. tropicalis, and C. krusei can have very different drug-resistance profiles. For instance, about three-quarters of C. krusei isolates and roughly a third of C. glabrata isolates are resistant to fluconazole.5Journal of Hospital Infection. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance If you take fluconazole and see no improvement after several days, the species causing your infection may simply not respond to that drug.
A newer option approved in 2021 is ibrexafungerp (brand name Brexafemme), which works through a completely different mechanism than fluconazole, targeting the fungal cell wall rather than the cell membrane. Clinical trials found it comparable to fluconazole for standard yeast infections, but it has a particular advantage against fluconazole-resistant strains and works better at the naturally low pH of the vagina.6PubMed Central. Ibrexafungerp: Mechanism of Action, Clinical, and Translational Science It is taken orally as two doses in a single day. If you have been through fluconazole without success, this is worth discussing with your provider.
Vaginal boric acid suppositories are another option, particularly for resistant infections. In a study of patients with fluconazole-resistant C. albicans, boric acid treatment achieved a mycological cure rate of about 86% and a clinical cure rate of about 74%.7Journal of Lower Genital Tract Disease. Fluconazole-Resistant Candida albicans Vaginal Infections at a Referral Center and Treated With Boric Acid These are used vaginally, never taken by mouth (boric acid is toxic if swallowed), and are typically a second-line option rather than a first choice.
Yeast Infections During Pregnancy
Pregnancy changes the equation in two ways. First, yeast infections are more common during pregnancy due to hormonal shifts that alter vaginal pH and sugar availability. Second, the treatment options narrow because oral fluconazole carries some risk when taken systemically during pregnancy, particularly at higher or repeated doses.
Topical azole antifungals (creams and suppositories like clotrimazole and miconazole) are the recommended first-line treatment during pregnancy. Data show that exposure to these topical treatments is not associated with an increased risk of birth defects.8PubMed Central. Vaginal yeast infections during pregnancy Systemic azoles like fluconazole, however, carry a dose-related concern for teratogenicity, and certain other antifungal drugs are outright contraindicated.9PubMed. Antifungal drugs in pregnancy: a review
The other important difference is duration. A Cochrane review of treatment in pregnancy found that 4-day courses were less effective than 7-day courses, while 7 days was just as effective as 14 days.10Cochrane Database of Systematic Reviews. Topical treatments for vaginal candidiasis (thrush) in pregnancy So the short 1- or 3-day regimens that work well outside of pregnancy may not be sufficient. Plan on at least a week of treatment if you are pregnant, and discuss options with your obstetrician rather than self-treating.
Dealing With Recurrent Infections
If you get four or more yeast infections in a year, the condition is classified as recurrent vulvovaginal candidiasis (RVVC), and the “get rid of it fast” approach shifts to a longer-term strategy. A landmark trial published in the New England Journal of Medicine tested weekly fluconazole for six months after an initial clearing course. During the treatment period, about 91% of women on fluconazole remained disease-free at six months, compared to 36% on placebo. But after stopping, infections gradually returned: by twelve months, only about 43% of the fluconazole group remained recurrence-free, versus 22% of the placebo group.11PubMed. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis The infection was suppressed effectively but not permanently cured in most cases.
A more recent network meta-analysis comparing maintenance strategies found that a newer drug called oteseconazole, taken weekly, was the most effective option tested for preventing recurrence, outperforming both fluconazole and topical clotrimazole maintenance regimens.12PubMed. Maintenance pharmacological therapy of recurrent vulvovaginal candidiasis. A Bayesian network meta-analysis of randomized studies Oteseconazole (brand name Vivjoa) was approved in 2022 specifically for preventing RVVC and represents a genuine step forward for people stuck in the cycle of repeated infections. That said, a European expert panel has cautioned that long-term azole exposure may increase the development of fluconazole-resistant strains, so ongoing monitoring matters.13PubMed Central. Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion
Do Probiotics Help?
Probiotics are widely marketed for vaginal health, and there is a biological rationale: Lactobacillus bacteria are the dominant residents of a healthy vagina, and they produce lactic acid and other metabolites that inhibit Candida growth.14PubMed Central. The role of Lactobacillus species in the control of Candida via biotrophic interactions Lab studies show that Candida growth slows significantly when the pH drops to the acidic range that lactobacilli maintain.15Scientific Reports. Vaginal lactobacilli inhibit growth and hyphae formation of Candida albicans
But moving from petri dishes to clinical outcomes has been frustrating. A systematic review and meta-analysis found that probiotics were no better than placebo at clearing an active yeast infection (as measured by positive cultures). They did, however, show a significant reduction in recurrence rates.16PubMed Central. The Role of Probiotics in the Treatment of Vulvovaginal Candidiasis: A Systematic Review and Meta-Analysis An earlier review reached a similar conclusion, noting that some specific Lactobacillus strains showed promise for prevention but that most clinical trials had small sample sizes, lacked control groups, or enrolled women without confirmed recurrent infections.17Journal of Antimicrobial Chemotherapy. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review
The honest assessment: probiotics are unlikely to cure an active infection faster, but they may help prevent the next one. If you are prone to recurrent yeast infections and tolerate probiotic supplements well, adding them is low-risk. Just do not rely on them as your primary treatment when you have active symptoms.
Risk Factors You Can Actually Change
Preventing infections is always faster than treating them. Several modifiable risk factors are well supported by evidence.
Poorly controlled blood sugar is a major one. High glucose levels increase vaginal glycogen, which lowers vaginal pH in a way that paradoxically favors Candida colonization rather than suppressing it, and provides the yeast with a richer food supply.18PubMed Central. The Interplay Between Sugar and Yeast Infections: Do Diabetics Have a Greater Predisposition to Develop Oral and Vulvovaginal Candidiasis? If you have diabetes, tighter glucose control reduces your risk of yeast infections along with many other complications.
Antibiotics are another common trigger, since broad-spectrum antibiotics kill off the protective Lactobacillus bacteria along with whatever infection they were prescribed for. You cannot always avoid antibiotics, but if you know they tend to trigger yeast infections for you, talk to your doctor about whether a single dose of fluconazole alongside the antibiotic course makes sense as a preventive measure.
A survey of women with recurrent infections found that the lifestyle changes they found most helpful were reducing sugar intake, keeping the vulvar area dry, and discontinuing oral contraceptive pills.19PubMed. Self-elimination of risk factors for recurrent vaginal candidosis These are self-reported observations rather than controlled trial results, but they align with what is known about the biology: moisture and warmth encourage yeast growth, and hormonal contraceptives can alter the vaginal environment. Cotton underwear, changing out of wet swimwear or workout clothes quickly, and avoiding scented soaps or douches in the genital area are standard practical advice.
Does Your Partner Need Treatment Too?
This comes up constantly, and the answer is surprisingly clear-cut: for vaginal yeast infections, treating the male sexual partner does not reduce cure rates or prevent recurrence. Multiple controlled trials have tested this directly. One double-blind randomized study found no difference in cure or recurrence rates whether or not the male partner received simultaneous antifungal treatment.20PubMed. Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study Another trial tracking recurrence over a full year found that 82% of women whose partners were untreated had recurrences versus 85% of women whose partners were treated, a difference that was not statistically meaningful.21Sexually Transmitted Infections. The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole A third study confirmed the same pattern.22PubMed. The value of treating the male partner in vaginal candidiasis
Yeast infections are not classified as sexually transmitted infections. Candida is a normal resident of the body that overgrows when conditions shift in its favor. While sexual contact can theoretically transfer yeast, the evidence consistently shows that the reinfection-from-partner theory does not hold up. If a male partner has symptoms of penile yeast infection (redness, itching, white patches on the skin), that warrants its own treatment, but treating him will not prevent your recurrences.
Diet and Intestinal Candida
You may have seen advice about “anti-Candida diets” that involve cutting out sugar, refined carbohydrates, alcohol, and fermented foods. The scientific evidence here is thin but not zero. A pilot study tested dietary modification alongside antifungal treatment for intestinal Candida overgrowth. Immediately after treatment, diet and non-diet groups had similar cure rates (around 70%). But at the three-month follow-up, 85% of patients who stuck with the dietary changes remained clear of overgrowth, compared to only about 43% of those who did not modify their diet.23PubMed. The dietary modification and treatment of intestinal Candida overgrowth – a pilot study
This was a small study focused on intestinal rather than vaginal Candida, so extrapolating directly is a stretch. But the gut is a known reservoir of Candida that can reseed vaginal infections, and reducing dietary sugar makes biological sense given how Candida feeds. A strict elimination diet is probably unnecessary for most people with an occasional yeast infection. For someone dealing with frequent recurrences, though, cutting back on refined sugar and simple carbs is a reasonable low-cost experiment alongside medical treatment.